Docetaxel/paclitaxel/pertuzumab/trastuzumabVarious toxicities: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1747卷 / 1期

关键词：

D O I：

10.1007/s40278-019-59756-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：115 / 115

相关论文

共 50 条

[21] Docetaxel/pertuzumab/trastuzumabDiarrhoea, acute renal failure and cardiac toxicities: 2 case reports
Reactions Weekly, 2018, 1731 (1) : 100 - 100
[22] Paclitaxel/pembrolizumab/temozolomideVarious toxicities: 3 case reports
Reactions Weekly, 2020, 1811 (1) : 223 - 223
[23] TrastuzumabVarious toxicities: case report
Reactions Weekly, 2018, 1726 (1) : 328 - 328
[24] Capecitabine/trastuzumabVarious toxicities: case report
Reactions Weekly, 2025, 2050 (1) : 134 - 134
[25] Docetaxel/fluorouracilHaematological toxicities: 4 case reports
Reactions Weekly, 2016, 1585 (1) : 102 - 102
[26] Docetaxel/nintedanibVarious toxicities: 6 case reports
Reactions Weekly, 2019, 1738 (1) : 110 - 110
[27] Docetaxel/paclitaxelCardiovascular toxicities: 6 case reports
Reactions Weekly, 2021, 1842 (1) : 158 - 158
[28] Docetaxel/sunitinibVarious toxicities: 4 case reports
Reactions Weekly, 2019, 1783 (1) : 107 - 107
[29] Docetaxel/ramucirumabVarious toxicities: 10 case reports
Reactions Weekly, 2019, 1777 (1) : 96 - 96
[30] Docetaxel/ramucirumabVarious toxicities: 12 case reports
Reactions Weekly, 2018, 1710 (1) : 123 - 123

← 1 2 3 4 5 →